V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002472 | 230008456 | 1.52 | 82 | Palliative (P) | null | 2020-01-30 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100269328 |
| 230002475 | 230008457 | 1.46 | 66.9 | null | 2020-07-11 | 2020-07-11 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101761464 |
| 230002476 | 230008458 | 1.47 | 69.4 | Palliative (P) | 2017-09-03 | 2017-09-17 | GEMCITABINE + TREOSULPHAN | 02 | N | PEMBROLIZUMAB | 101211855 |
| 230002479 | 230008460 | 1.5 | 94 | Palliative (P) | 2019-09-15 | 2021-05-07 | null | null | N | LIPOSOMAL DOXORUBICIN | 100934528 |
| 230002482 | 230008461 | 1.57 | 68.5 | null | null | 2018-11-14 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 100170870 |
| 230002483 | 230008462 | 1.68 | 54.5 | Adjuvant (A) | 2017-01-30 | 2017-07-16 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101660639 |
| 230002484 | 230008463 | null | null | null | 2018-08-22 | 2018-08-23 | Carboplatin + Docetaxel | 02 | null | IPILIMUMAB + NIVOLUMAB | 101190704 |
| 230002485 | 230008464 | 1.65 | 61 | null | null | 2021-01-24 | CISPLATIN + ETOPOSIDE | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100995054 |
| 230002486 | 230008465 | 1.62 | 101 | Adjuvant (A) | 2018-05-10 | 2020-02-04 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100313597 |
| 230002487 | 230008466 | 1.7 | 75.9 | Palliative (P) | 2018-05-14 | 2020-07-02 | PACLITAXEL | 02 | N | PACLITAXEL | 101429779 |
| 230002490 | 230008468 | 1.52 | 55.8 | null | 2017-12-12 | 2018-09-06 | null | null | null | CISPLATIN | 100598119 |
| 230002491 | 230008469 | 0 | 56.8 | Palliative (P) | 2017-06-13 | 2017-06-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101557719 |
| 230002493 | 230008470 | null | null | Palliative (P) | 2019-11-11 | 2019-11-13 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100741089 |
| 230002495 | 230008472 | 1.7 | 61 | Palliative (P) | null | 2018-10-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100958318 |
| 230002496 | 230008473 | 1.5 | 64.3 | Palliative (P) | null | 2020-08-23 | null | null | N | CYCLOPHOSPHAMIDE | 100025980 |
| 230000127 | 230008474 | null | null | 03 | 2019-12-20 | 2020-01-23 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101739748 |
| 230000346 | 230008475 | 1.53 | 65 | Adjuvant (A) | null | 2019-04-20 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101512272 |
| 230000353 | 230008476 | 1.69 | 92.6 | null | null | 2019-06-23 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101630688 |
| 230000394 | 230008477 | null | null | null | 2021-04-13 | 2021-09-14 | Bevacizumab+Carbo+Pacliaxel | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100919016 |
| 230000408 | 230008479 | 1.57 | null | null | 2021-02-28 | 2021-04-14 | Cisplatin + Liposomal Doxorubicin | 02 | null | IPILIMUMAB | 100874156 |
| 230000660 | 230008482 | null | null | Palliative (P) | 2020-09-04 | 2020-09-11 | PEMBROLIZUMAB | 02 | N | GEMCARBO | 101858698 |
| 230000677 | 230008483 | 1.52 | 56 | null | null | 2021-03-24 | null | null | null | NIRAPARIB | 101324249 |
| 230000680 | 230008484 | 1.66 | 105.3 | null | 2020-09-02 | 2020-10-05 | PACLITAXEL | 02 | null | PACLITAXEL | 100052373 |
| 230000700 | 230008485 | 1.63 | 82 | Palliative (P) | 2019-11-05 | 2020-04-17 | Cisplatin + Radiotherapy | 02 | N | IPILIMUMAB + NIVOLUMAB | 100011679 |
| 230000703 | 230008486 | 1.69 | 74.6 | Palliative (P) | null | 2019-12-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101564626 |
| 230000792 | 230008487 | 1.61 | 50.9 | null | 2020-09-06 | 2020-10-04 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101743297 |
| 230000798 | 230008488 | 1.58 | 63.2 | Palliative (P) | 2021-08-09 | 2021-08-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100294403 |
| 230000869 | 230008489 | null | null | Adjuvant (A) | 2020-10-18 | 2020-11-10 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101278961 |
| 230000936 | 230008491 | 1.72 | 95.6 | Curative (C) | 2017-10-04 | 2017-10-09 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101772973 |
| 230000965 | 230008492 | 1.53 | 56.8 | null | 2021-07-11 | 2021-07-11 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101177171 |
| 230001073 | 230008494 | null | null | Palliative (P) | 2021-04-12 | 2021-04-20 | null | N | N | ICON8B TRIAL | 101228963 |
| 230001080 | 230008495 | null | null | null | 2017-12-03 | 2017-12-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101443279 |
| 230001176 | 230008496 | 1.47 | 101 | null | 2019-03-04 | 2019-09-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101863872 |
| 230001395 | 230008499 | 1.62 | 61.7 | Palliative (P) | 2020-09-07 | 2020-09-29 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 100397809 |
| 230001437 | 230008500 | null | null | null | 2021-02-13 | 2021-07-21 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101374920 |
| 230001623 | 230008502 | null | null | null | 2021-12-01 | 2021-12-16 | Niraparib | 02 | null | NIRAPARIB | 101131334 |
| 230001657 | 230008503 | 1.56 | 71 | null | 2021-05-18 | 2021-06-07 | null | 02 | null | BEVACIZUMAB + CARBO + PACLITAXEL | 101223342 |
| 230001703 | 230008504 | 1.54 | 101 | Palliative (P) | 2021-01-15 | 2021-06-13 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100273130 |
| 230002075 | 230008507 | null | null | null | 2019-02-25 | 2019-03-04 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101208932 |
| 230002111 | 230008508 | null | null | Adjuvant (A) | 2021-05-19 | 2022-05-15 | null | null | N | LIPOSOMAL DOXORUBICIN | 101356988 |
| 230002146 | 230008509 | 1.62 | 70 | null | null | 2017-06-21 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100649868 |
| 230002153 | 230008510 | 1.78 | 41.1 | null | 2019-10-28 | 2019-11-08 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100775832 |
| 230002163 | 230008511 | 1.62 | 68.6 | null | 2022-02-21 | 2022-02-26 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | PACLITAXEL | 101233285 |
| 230002202 | 230008512 | 1.58 | 51.2 | Palliative (P) | 2015-08-16 | 2017-01-19 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101517166 |
| 230002313 | 230008513 | 1.51 | 0 | null | 2020-02-25 | 2020-03-12 | PACLITAXEL | 02 | null | PACLITAXEL | 101541704 |
| 230002376 | 230008515 | 1.65 | 70 | null | 2021-01-20 | 2021-02-02 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100845043 |
| 230002409 | 230008516 | null | null | Curative (C) | null | 2018-08-28 | PACLITAXEL | 02 | N | PACLITAXEL | 100843848 |
| 230001673 | 230008520 | 1.52 | 47.5 | null | 2020-04-16 | 2020-04-23 | null | null | null | BEVACIZUMAB | 101631811 |
| 230001101 | 230008950 | 1.52 | 58.5 | Adjuvant (A) | 2020-02-15 | 2020-06-08 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 101102632 |
| 230001103 | 230008952 | null | null | null | null | 2019-02-21 | Carboplatin + Paclitaxel (weekly) | null | null | CARBOPLATIN + PACLITAXEL | 101205733 |